#United States #Medical Devices #Salt Lake City #Biomerics #Liran Avigad Greiner

Biomerics Expands Leadership in International Division

Biomerics, recognized as a top vertically integrated contract manufacturer in the interventional medical device market, has made headlines with the appointment of Liran Avigad Greiner as the President of their International Division. This significant move aims to leverage her expertise to drive growth in the Costa Rican operations.

A New Chapter at Biomerics

On June 1, 2026, Biomerics announced the promotion of Avigad Greiner, who takes over from Chris Richardson, the Chief Commercial Officer who temporarily filled the presidential role over the last year.

Arun Mohan, Biomerics' CEO, underscored the importance of this transition, stating, "Biomerics' success is built on strong culture, innovation and manufacturing excellence, with a relentless focus on our customers. Liran embodies each of those principles." Her diverse experience in operations and product development positions her as the perfect candidate to lead the International Division into its next growth phase.

Avigad Greiner expressed her enthusiasm: "I am humbled by this opportunity to lead Biomerics' International Division. I'm deeply proud of the role we play in improving and saving lives through the cutting-edge components, subassemblies, and finished medical devices we produce every day. I look forward to driving customer-centric alignment between manufacturing execution and product development to consistently ensure high-quality, scalable, and efficient outcomes."

Biomerics' Operations in Costa Rica

As President, Avigad Greiner will oversee Biomerics' advanced operations based in Costa Rica, which includes a wide range of commercial, engineering, and project management teams. The focus will be on not only maintaining but enhancing the high standards of quality and efficiency for which Biomerics is known.

Biomerics, founded in 1994, primarily serves the interventional medical device sector and is trusted by 20 of the top 30 medical device Original Equipment Manufacturers (OEMs) globally. With over 10 operational locations, including two in Costa Rica and one in the Dominican Republic, the company has built a reputation for quality and reliability.

Commitment to Quality and Innovation

Biomerics utilizes a certified ISO 134852016 quality system and is FDA registered, complying with FDA 21 CFR Part 820. This regulatory commitment ensures that all products meet stringent safety and efficacy standards. The company prides itself on its engineering capabilities, offering extensive services in areas such as performance materials, interventional medical plastics, and advanced machining techniques.

The innovation at Biomerics is not just confined to its products, but also extends to its leadership approach. The promotion of a proven internal candidate speaks volumes about the company's strong leadership culture and its commitment to fostering talent within its ranks.

Conclusion

With the appointment of Liran Avigad Greiner, Biomerics is setting the groundwork for a new wave of growth and innovation within its International Division. Her leadership is expected to enhance the company's commitment to advancing medical technology, making a meaningful impact on healthcare outcomes worldwide. As Biomerics continues to evolve, the focus will remain on creating high-quality, innovative medical products that save lives and improve patient care.